Reduced likelihood of realizing cost savings in the PB business through technology transfer from Bespokify
First written in FY2020-Q2. 2 of 3 entries say "Restated". Latest entry: FY2022-Q2.
The whole theme swung hardest in 2019: 10 of 27 companies on the "Worse" side.
14 other companies' latest entry also says "Restated".
- FY2022-Q2RestatedAnnual report
「During the second quarter of the fiscal year, there were no material changes in the occurrence of major risks that management recognizes as potentially having a material impact on the financial position, operating results or cash flows of the consolidated companies, among the matters relating to the business conditions, financial position and other matters described in this quarterly report, or in the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
The Company explained that there had been no material change in the lower likelihood of realizing cost savings in the private-label business from redeploying Bespokify's technology. - FY2022-Q1RestatedAnnual report
「During the cumulative first-quarter consolidated period, there were no material changes in matters described in this quarterly report concerning the status of the business, financial information and other matters that could materially affect investors' decisions, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company explained that there had been no material change in the lower likelihood of realizing cost savings in the private-label business from redeploying Bespokify's technology. - FY2020-Q2MaterialisedAnnual report
「At Bespokify Pte., Ltd., an unconsolidated subsidiary of the Company, the likelihood decreased that the anticipated reduction in operating costs in the Company's private-label business from redeploying Bespokify's proprietary technology for automatically generating garment patterns would materialize as initially expected.」
The likelihood that the operating cost savings in the private-label business premised on redeploying Bespokify's technology would materialize as initially expected declined, and an impairment loss on investment securities of ¥1,150 million was recognized.